Coronavirus disease 2019 (COVID-19) and immune-mediated rheumatic diseases. Recommendations of the association of rheumatologists of Russia
E. L. Nasonov,A. M. Lila,Vadim I. Mazurov,B. S. Belov,A. E. Karateev,Tatiana Dubinina,O. A. Nikitinskaya,A. A. Baranov,Diana Abdulganieva,S. V. Moiseev,A. I. Zagrebneva +10 more
- Vol. 59, Iss: 3, pp 239-254
Reads0
Chats0
TLDR
The new version of the recommendations of the Association of Rheumatologists of Russia formulates the main provisions concerning the tactics of managing patients with Immune-mediated Rheumatic Diseases during the ongoing COVID-19 pandemic.Citations
More filters
Journal ArticleDOI
Деплеция в-клеток при иммуновоспалительных ревматических заболеваниях и коронавирусная болезнь 2019 (covid-19)
Е. Л. Насонов,А. С. Авдеева +1 more
TL;DR: According to the recommendations of the Association of Rheumatologists of Russia, a more rigorous assessment of indications for induction and maintenance therapy of RTX therapy and harmonization of the timing of drug administration and vaccination is required.
Journal ArticleDOI
Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues
TL;DR: The frequency of exacerbation of RD after vaccination against COVID-19 seems to be quite low (5–7%) and has no significant associations with a specific vaccine or anti-rheumatic therapy, and unambiguous interpretation is difficult.
Journal ArticleDOI
Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology
Evgeny Nasonov,T.V. Korotaeva +1 more
TL;DR: The current achievements, trends and recommendations regarding the use of JAK inhibitors in the treatment of IMIDs and also in the hyper-response phase of COVID-19 are reviewed.
Journal ArticleDOI
Rheumatoid arthritis and post-COVID-19 syndrome
TL;DR: It is thought that SARS-CoV-2 infection may be a trigger factor for new rheumatic musculoskeletal diseases, including rheumatoid arthritis or COVID-19 can unmask previously undetected RA, and arthritis in the post covid period may induce problems in differential diagnosis of rhematic diseases.
Journal ArticleDOI
Safety of COVID-19 vaccines in patients with immunoinflammatory rheumatic diseases (preliminary data)
TL;DR: Preliminary data suggest that vaccination against COVID-19 in patients with IRD appears to be quite safe, and further studies are needed to investigate the safety, immunogenicity, and clinical efficacy of CO VID-19 immunization in rheumatic patients.
References
More filters
Journal ArticleDOI
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.
Ted R. Mikuls,Sindhu R. Johnson,Liana Fraenkel,Reuben J. Arasaratnam,Lindsey R. Baden,Bonnie L. Bermas,W. Winn Chatham,Stanley Cohen,Karen H. Costenbader,Ellen M. Gravallese,Andre C. Kalil,Michael E. Weinblatt,Kevin L. Winthrop,Amy S. Mudano,Amy S. Turner,Kenneth G. Saag +15 more
TL;DR: To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID‐19) pandemic.
Journal ArticleDOI
Systemic and organ-specific immune-related manifestations of COVID-19.
TL;DR: The signs and symptoms associated with this excessive immune response are very diverse and can resemble some autoimmune or inflammatory diseases, with the clinical phenotype that is seemingly influenced by epidemiological factors such as age, sex or ethnicity.
Journal ArticleDOI
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases - Version 1.
Jeffrey R. Curtis,Sindhu R. Johnson,Donald D. Anthony,Reuben J. Arasaratnam,Lindsey R. Baden,Anne R. Bass,Cassandra Calabrese,Ellen M. Gravallese,Rafael Harpaz,Rebecca E Sadun,Amy S. Turner,Eleanor Anderson Williams,Ted R. Mikuls +12 more
TL;DR: To provide guidance to rheumatology providers on the use of coronavirus disease 2019 (COVID‐19) vaccines for patients with rheumatic and musculoskeletal diseases (RMDs).
Posted ContentDOI
More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis
Sandra Lopez-Leon,Talia Wegman-Ostrosky,Carol Perelman,Rosalinda Sepulveda,Paulina A. Rebolledo,Angelica Cuapio,Sonia Villapol,Sonia Villapol +7 more
TL;DR: In this paper, a systematic review and meta-analysis aimed to identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID19 stage.
Journal ArticleDOI
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases.
David Simon,Koray Tascilar,Filippo Fagni,Gerhard Krönke,Arnd Kleyer,Christine Meder,Raja Atreya,Moritz Leppkes,Andreas E. Kremer,Andreas Ramming,Milena L Pachowsky,F. Schuch,Monika Ronneberger,Stefan Kleinert,Axel J. Hueber,K. Manger,Bernhard Manger,Carola Berking,Michael Sticherling,Markus F. Neurath,Georg Schett +20 more
TL;DR: In this paper, a large COVID-19 study was conducted to understand the factors that influence the humoral immune response to vaccination against SARS-CoV-2 in patients with immune-mediated inflammatory diseases (IMIDs).